Literature DB >> 16225978

Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder.

Chuan-Chia Chang1, I-Shin Shiah, Hsin-An Chang, San-Yuan Huang.   

Abstract

Toxic epidermal necrolysis (TEN) is the most severe and potentially life-threatening cutaneous reaction associated with lamotrigine. The risk of developing TEN during lamotrigine therapy is low and previously reported cases most involved epileptic patients. However, the risk of TEN with combination lamotrigine and valproate is greater than with monotherapy. We present here the emergence of TEN in a 32-year-old bipolar woman who was concomitantly treated with lamotrigine and valproate. The patient developed high fever, pharyngitis, cervical lymphadenopathy, mucosal sloughing, generalized erythematous eruptions and more than 40% epidermal detachment of the total body surface area (TBSA) after we added lamotrigine to her medications of valproate and trazodone. The patient's illness course was protracted and accompanied with hepatitis, pneumonitis and hematologic abnormalities. In the beginning of her illness course, our patient did not respond to antihistamine treatment. However, she made a full recovery without any sequela after she had received systemic corticosteroid and intensive resuscitation. Our case suggests that early use of systemic corticosteroid might be beneficial in treating TEN patients, if there is not any clinical contraindication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225978     DOI: 10.1016/j.pnpbp.2005.08.025

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Adverse Effects of Antiepileptic Drug Lamotrigine and Oral Implications: Case Report.

Authors:  Ana Ivanišević Malčić; Đurđica Sivić; Jurica Matijević
Journal:  Acta Stomatol Croat       Date:  2017-06

2.  Toxic epidermal necrolysis induced by lamotrigine treatment in a child.

Authors:  Youngsuk Yi; Jeong Ho Lee; Eun Sook Suh
Journal:  Korean J Pediatr       Date:  2014-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.